Medicus Pharma Ltd.
Formerly Interactive Capital Partners Corporation
Medicus Pharma Ltd. is listed today as Medicus Pharma Ltd.: market value, financials and filings are on its company page.
Funding rounds
1 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| May 2024 | $11 M | No. 1 | $10 to $50 million | equity, debt, options | SEC | |
| Sep 2023 | $5 M | Issued in a merger or acquisition | $2 to $10 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Medicus Pharma Ltd. chose not to state its revenue in its newest notice of a funding round (Jul 2024).
SEC Form D · Jul 2024
The industry group it chose in its notices: Other Health Care.
SEC Form D · Jul 2024
That is all the official record says: Medicus Pharma Ltd. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services of Medicus Pharma Ltd. are on record.
Investors#
No investor of Medicus Pharma Ltd. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 23 investors.
Largest shareholders today
Institutions holding Medicus Pharma Ltd. shares, as of Sep 30, 2026.
- Staley Capital Advisers Inc$0 M0.52%
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Carolyn J. Bonner | President | Jul 2024 |
| Edward J. Brennan | Chief Medical Officer | Jul 2024 |
| Erica J. Monaco | Chief Operating Officer | Jul 2024 |
| James J. Quinlan | Chief Financial Officer | Jul 2024 |
| Raza J. Bokhari | Chairman and Chief Executive Officer | Jul 2024 |
| Barry J. Fishman | Director | Jul 2024 |
| Frank J. Lavelle | Director | Jul 2024 |
| Larry Kaiser | Director | Jul 2024 |
| Raza J. Bokhari | Chairman and Chief Executive Officer | Jul 2024 |
| Robert J. Ciaruffoli | Director | Jul 2024 |
| Sara R. May | Director | Jul 2024 |
| William L. Ashton | Director | Jul 2024 |
Went public since 2024. Its SEC number is that of a company listed on a stock exchange.